Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wonderlab Yitong is a probiotic dietary supplement developed through a strategic collaboration between the nutrition brand WonderLab (Shenzhen Precision Health Food Technology) and the Guangdong Provincial People's Hospital. Specifically designed to manage functional constipation, the formulation contains a high concentration of live probiotic strains, including *Bifidobacterium animalis* subsp. *lactis* (BLa80) and other beneficial bacteria. The product functions by modulating the host's gut microbiota, promoting the production of short-chain fatty acids, and stimulating intestinal peristalsis to improve bowel movement frequency and stool consistency. It is widely available in China as a health supplement (nutraceutical) rather than a prescription pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wonderlab Yitong.